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Abstract Stigma remains a significant barrier to HIV
testing in South Africa. Despite being a social construct,
most HIV-stigma research focuses on individuals; further
the intersection of gender, testing and stigma is yet to be
fully explored. We examined the relationship between
anticipated stigma at individual and community levels and
recent testing using a population-based sample (n = 1126)
in Mpumalanga, South Africa. We used multi-level
regression to estimate the potential effect of reducing
community-level stigma on testing uptake using the
g-computation algorithm. Men tested less frequently (OR
0.22, 95% CI 0.14–0.33) and reported more anticipated
stigma (OR 5.1, 95% CI 2.6–10.1) than women. For men
only, testing was higher among those reporting no stigma
versus some (OR 1.40, 95% CI 0.97–2.03; p = 0.07). For
women only, each percentage point reduction in commu-
nity-level stigma, the likelihood of testing increased by 3%
(p\ 0.01). Programming should consider stigma reduction
in the context of social norms and gender to tailor activities
appropriately.
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Background
With the fourth highest adult HIV prevalence (19.1%) and
the second highest number of HIV-related deaths in the
world [1, 2], South Africa requires a broad response to the
HIV epidemic. As a result, the government has imple-
mented mass HIV testing campaigns and operates the
world’s largest antiretroviral (ART) program, with con-
tinued expansion of ART access [3, 4]. Despite significant
increases in HIV testing [5], data from the most recent
national survey (which included HIV-testing) indicate that
only 37.8% of HIV-positive men and 55.0% of HIV-posi-
tive women in South Africa were aware of their HIV status
[6]. Because a substantial proportion of new infections are
spread by persons unaware of their HIV status [7], there is
an immense need for increased testing uptake and fre-
quency. Knowledge of one’s HIV status enables people
living with HIV (PLHIV) to maximize the benefits of early
HIV treatment and reduce the likelihood of further
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anticipated stigma and HIV testing uptake by gender in a
population-based survey conducted in a rural, high preva-
lence area of South Africa.
Methods
Study Setting
We conducted a cross-sectional, population-based survey
among a random sample of 581 men and 600 women ages
18–35 in 22 villages in rural Mpumalanga Province,
northeast South Africa, from February to June 2012. The
survey was undertaken as part of a two-year cluster ran-
domized controlled trial of a community mobilization
intervention to change inequitable gender norms, particu-
larly among men [30]. The research took place in the
Agincourt Health and Socio-Demographic Surveillance
System Site (HDSS), about 500 km northeast of Johan-
nesburg. The 22 villages included in this study make up the
entirety of the Agincourt Health and Demographic
Surveillance System, except one village which was
excluded as it was significantly smaller than the others. The
22 villages vary in terms of size, ranging from 0.72 to
6.48 km2, with populations between 800 and 9000 at the
time of the study. The entire area is characterized by high
levels of unemployment, a significant population of tem-
porary labour migrants (who migrate out of the area for
work) and high HIV prevalence, estimated at 45% for
35–39 year-old males and females [31, 32].
Sample and Procedures
Individuals aged 18–35 were randomly selected from the
Agincourt HDSS census, from among all men and women
living in the 22 participating study villages [30]. Partici-
pation in the Agincourt HDSS census is almost universal
(two households choose not participate in the census) [32].
The target enrollment for each of the 22 communities was
55 individuals with 27–28 males and females per com-
munity. Only one individual per household was sampled
for recruitment to avoid clustering at the household level.
Eligibility criteria for participation in the survey included:
residence in the home (spends a majority of nights in a
7-day week within the home), age 18–35 years, and having
lived in the study area for the past 12 months.
After eligibility was confirmed and informed consent
obtained, surveys were conducted in participants’ house-
holds. Interviews and informed consent procedures were
conducted in Shangaan (local language) or English,
depending on the participant’s preference. We used com-
puter assisted personal interviewing (CAPI), in which the
interviewer read each question to the respondent, then
transmission [8]. Furthermore, knowing one’s status has 
been associated with the adoption of lower risk behaviours 
among PLHIV [9, 10].
As has been noted since early in the HIV epidemic, 
stigma is a key barrier to effective prevention and treat-
ment efforts [11]. Individual perceived stigma, or the fear 
of being stigmatized if positive, have long been associated 
with delays in testing or decisions not to test, and this had 
been shown to be the case both before [12–19] and after 
South Africa expanded access to HIV care and treatment 
[20–22]. To date, most of what is known about the rela-
tionship between stigma and HIV testing has focused on 
individual-level models, or those that examine an individ-
ual’s perception of HIV-related stigma and its association 
with testing decisions [23]. However, stigma is an inher-
ently social construct that can only manifest in a context 
where power structures exist; differences are identified, 
labelled and valued; and those deemed ‘different’ are 
actively ‘othered’ and devalued [11, 24]. The potential of 
being stigmatized because of a certain identity or behaviour 
is socially communicated—one’s perception is informed 
by considering the attitudes of others who are part of the 
same community. As a result, it is important to understand 
how living in an environment or community where others 
anticipate stigma impacts testing behaviours [25]. In this 
study, we operationalize community-level stigma by 
looking at the percent of people in a village reporting 
perceived stigma. This approach allows us to examine the 
impacts of living in village where a lot of people fear 
stigma (or not), independent of your own fears of stigma, 
and its impacts on individual testing. Examining how the 
social environment impacts individual testing behaviour 
can create pathways to structural interventions to increase 
HIV testing [25].
While exploring the statistical relationship between 
stigma and testing through a community lens is a nascent 
field, some investigators have noted important relation-
ships. For example, in Nigeria, Babaloa found that men 
living in communities with more stigma were 43% less 
likely to be ready for HIV-testing than men who lived in 
communities with less stigma [26]. Smolak found that 
among women in Central Asia, stigma at every level—the 
individual, family and community—were significant pre-
dictors of HIV testing [27]. In Sierra Leon, community 
adherence to stigmatizing attitudes towards people living 
with HIV was negatively associated with individual-level 
recent HIV testing [23].
With continued emphasis on the importance of testing 
early and often [8, 28, 29], understanding the barriers to 
testing at multiple levels is paramount to inform prevention 
and treatment programming targeting high prevalence 
areas. As such, we explore the relationship between indi-
vidual-level anticipated stigma, community prevalence of
entered the answer into an electronic form on a laptop
computer. While this secondary analysis focused on vari-
ables regarding HIV testing, stigma and demographics,
data was also collected on community mobilization
domains, gender roles and equitable norms, sexual risk
behavior, HIV treatment and disclosure, violence, sub-
stance use and exposure to program activities; as such, it
took 1–2 hours to complete the survey. No financial com-
pensation was provided for participation in the study per
study site policy.
The Institutional Review Boards at the University of
North Carolina-Chapel Hill and the University of Califor-
nia, San Francisco, and the Human Research Ethics
Committee at the University of the Witwatersrand in South
Africa approved this study.
Measures
Socio-demographic characteristics evaluated included
gender, age group (18–24, 25–29, and 30–35), marital
status (never married, married, separated or divorced,
widowed), educational attainment (primary school or less,
some high school, completed high school, tertiary), earned
income over past 3 months (any vs. none), and past month
household food insecurity (any days where any household
member did not eat vs. none). We defined recent HIV
testing as having tested in the past 12 months. Anticipated
HIV stigma was operationalized using a 9-item scale pre-
viously validated in sub-Saharan Africa that includes
questions that assess expectations of discrimination should
one become HIV positive (e.g. ‘‘You would be treated
badly at work or school’’) [17, 33]. Participants were
classified as reporting anticipations of stigma if they
answered ‘‘very likely’’ or ‘‘likely’’ to any of the nine
questions. The decision to dichotomize responses as any
versus no anticipated stigma was based on review of
graphical depictions of the distribution of our continuous
stigma variable whereby the majority of our sample
reported no anticipated stigma, and no clear-cut breaks
were evident between medium versus high levels of
stigma; thus, we did not want to make assumptions about
the functional form of the stigma variable. Community-
level stigma was calculated by estimating the weighted
proportion of individuals within each village who reported
any anticipated stigma, excluding the index individual.
Analysis
Univariate analyses were conducted to describe the socio-
demographic characteristics of the population, stratified by
gender. We then estimated a series of logistic regression
models among individuals who did not report HIV-positive
status. These models evaluate the relationships between (1)
individual-level stigma and recent HIV testing; (2) com-
munity-level stigma and recent HIV testing; and (3) both
individual-level stigma and community-level stigma within
the same model predicting recent HIV testing. All models
were run separately by gender and were adjusted for age
group and educational attainment. Data for the response to
one stigma variable was imputed for one participant who
was missing only one of the nine stigma questions; 53
participants were excluded from analysis as they were
missing data on all nine of the anticipated stigma questions.
The 53 participants excluded for non-response to stigma
variable did not differ from those who did respond in terms
of village of residence, gender, age, marital status or edu-
cational attainment.
We also employed the g-computation algorithm, an
imputation-based causal inference method, to estimate the
potential effect of an intervention [34, 35]. This method
was developed to control for time-dependent confounding
within longitudinal analysis; however, it is also well suited
to the estimation of population parameters under hypo-
thetical interventions within cross-sectional studies [34].
We used this method to predict what HIV testing uptake
can be expected based on changing levels of community
stigma, accomplished by imputing each individual’s
probability of recent HIV testing under different commu-
nity-stigma scenarios corresponding to the range of the
observed data. This process estimates the missing coun-
terfactuals through imputing each individual’s probability
of recent HIV testing if he/she had experienced a com-
munity stigma value that he/she did not experience based
on individual characteristics and the risk associated with
the particular community-level stigma value. Individual
testing was predicted from 25 to 65% of the community
reporting any stigma, at 5% intervals. We included
covariates for age group, educational attainment and per-
cent of village residents who were temporary migrants,
defined as having spent less than 6 of the last 12 months in
the area [36].
Participants self-reported HIV status. We did not include
participants in our analytic sample if they reported an HIV-
positive status. This decision was based on the assumption
that a positive HIV-status would influence both the par-
ticipant’s anticipated stigma and their testing behavior (i.e.
there is no need to test if you know you are HIV positive.)
However, substantially fewer participants reported a posi-
tive HIV status than would expected based on district data.
As such, we conducted a sensitivity analysis to explore
how reported HIV status might impact the findings. As our
analysis sample only included individuals self-reporting a
HIV-negative status (some of whom likely have a positive
status and therefore may have a different relationship to
stigma or testing), we looked at the relationships between
our variables of interest (1) only among those self-
reporting a HIV-positive status and (2) among the full
sample. We then compared these values to findings of those
self-reporting a HIV-negative status, to get a sense of the
directionality of the bias.
Analyses were stratified by gender, weighted to account
for the survey design and utilized robust standard errors to
accommodate for potential clustering at the community
level. All analyses were conducted in Stata 14 (StataCorp
LP, College Station, TX). Sampling weights included the
reciprocal of the probability of including a subject in the
sample based on the number of eligible individuals of that
gender in the community and household.
Results
Eighty-one percent of sample households were visited;
target sample size was reached in some villages before the
entire sample was exhausted. Of the households contacted,
69% included an eligible resident and 94% of those eligible
enrolled in the study (n = 1181; 600 women and 581 men).
Demographics of our sample are presented in Table 1. Men
were younger than women with 75.2% of male participants
aged 18–24 compared to only 51.1% of women. The
majority of both men and women had not completed ter-
tiary education, and only 32.1% of men and 40.0% of
women reported having earned any income in the past three
months. Only 2% of men and 6.9% of women self-reported
positive HIV status. Participants excluded for non-response
to the anticipated stigma scale were similar to those
included in terms of gender, age group, marital status, and
educational attainment. However, they differed signifi-
cantly in socio-economic status (SES), where those missing
stigma variables had lower SES, as measured by any
earned income in the past 3 months and any household
food insecurity in the past month.
Men tested less frequently than women (OR 0.22, 95%
CI 0.14–0.33; p\ 0.01; data not shown), with 43.3% of
men and 78.9% of women reporting having tested in the
last 12 months (Table 1). The odds of reporting any indi-
vidual anticipated stigma was five times higher among men
compared to women at 61.8% versus 23.9% respectively
(OR 5.1, 95% CI 2.6–10.1, p\ 0.001; not shown). Table 2
documents the percent of men and women agreeing with
the nine questions included in our composite internalized
stigma variable. The mean proportion of individuals
reporting anticipated stigma across communities was 41.5
(SD 10.3). By village, proportions of individuals reporting
anticipated stigma ranged from 24.0% to 65.6%.
Our multivariate models found that men reporting no
individual-level stigma (vs. any) were 40% more likely to
have tested within the past year, though this did not reach
statistical significance (OR 1.40, 95% CI 0.97–2.03,






Males Females Pearson’s p value
wt% 95% ci wt% 95% ci X2
Age group 26.93 \0.001
Age 18–24 75.2 (70.3–79.6) 51.1 (45.8–56.4)
Age 25–29 15.6 (12.7–18.9) 24.0 (19.6–29.0)
Age 30–35 9.2 (5.7–14.5) 24.9 (20.0–30.7)
Marital status 23.28 \0.001
Never married 84.9 (79.6–89.1) 66.3 (60.0–72.0)
Married 9.6 (6.6–13.7) 30.4 (24.9–36.5)
Separated/divorced 5.2 (3.2–8.3) 2.2 (1.1–4.2)
Widowed 0.3 (0.0–1.0) 1.1 (0.5–2.4)
Educational attainment 3.33 0.04
Completed primary or less 11.8 (6.9–19.3) 9.3 (6.7–12.8)
Some high school 59.4 (53.8–64.7) 51.6 (44.4–58.7)
Completed high school 26.7 (21.6–32.6) 37.0 (28.8–46.1)
University/technikon 2.1 (1.2–3.7) 2.1 (0.1–4.4)
Any income past 3 Mo 32.1 (26.5–38.4) 40.0 (35.4–44.7) 6.58 0.02
Any household food insecurity 2.5 (1.3–4.9) 3.2 (1.8–5.5) 0.45 0.51
HIV test last 12 Moa 43.7 (37.8–49.9) 78.9 (72.9–83.4) 86.29 \0.001
HIV positive 2.0 (0.1–6.2) 6.9 (4.9–9.7) 3.93 0.06
Weights account for sampling
a Excludes participants reporting positive HIV-status
with recent testing behaviour among women (Table 3).
Analysis of community-level stigma demonstrated a sig-
nificant association among women such that for each per-
centage point reduction in community-level stigma, the
odds of recent HIV testing increased by 3% (p\ 0.01).
The significant association persisted after accounting for
individual-level stigma, age, education and community
proportion of migrants. Community-level stigma was not
associated with testing among men.
Estimated gains in HIV testing at different levels of
community stigma using the g-computation algorithm are
presented in Fig. 1. Our results indicate that community-
level interventions focused on decreasing community
stigma could result in significant increases in testing for
women, but not men. For example, if women living in
villages where 50% of the village reported stigma as
opposed to a village where only 25% of the community
reported stigma, we should expect a 12.0 percentage point
increase in the number of women reporting recent HIV
testing.
Sensitivity analysis found that men self-reporting a
HIV-positive status had significantly lower rates of antic-
ipated stigma (12%) than men reporting a HIV-negative
status (62%). Further, men self-reporting a HIV-positive
status also reported higher rates of recent HIV testing
(62%) than men reporting a HIV-negative status (43%).
Table 2 Percent reporting very or somewhat likely responses to internalized stigma indicators by gender, Agincourt sub-district, Mpumalanga
province, South Africa
Males Females
wgt % 95% ci wgt % 95% ci
‘‘Different people feel differently about people who have HIV/AIDS. Now I am going to ask you to tell me what might happen to you if you were
to test positive for HIV and told others your status. For each statement, please tell us if the following situations are very likely, somewhat likely,
or unlikely.’’
Agree with any internalized stigma indicators 61.8 (54.5–68.6) 23.9 (16.1–34.1)
You would experience a break-up of your marriage or relationship 33.5 (26.7–41.2) 16.2 (10.7–28.9)
You would experience physical abuse by your spouse/partner(s) 28.4 (21.8–36.2) 15.3 (10.3–22.0)
You would lose your job/livelihood 22.6 (17.4–28.8) 8.9 (5.5–13.9)
You would be treated badly at work or school 28.6 (23.4–34.8) 11.4 (7.4–17.0)
You would lose your friends 32.3 (27.3–37.8) 14.3 (9.6–20.6)
You would be disowned from or neglected by your family 12.4 (8.3–17.9) 10.6 (6.9–15.8)
You would be treated badly by health professionals 22.5 (16.3–30.1) 11.3 (6.7–18.4)
Your community(village) would treat you like a social outcast 36.7 (27.5–46.9) 15.8 (10.1–23.7)
Your family would not care for you if you became sick 11.6 (7.5–17.6) 10.3 (6.1–16.8)
Weights account for sampling; excludes participants reporting positive HIV-status
Table 3 Logistic regression
analysis predicting past year
HIV testing among HIV-




Anticipated stigma Univariate Multivariatea
% 95% CI OR 95% CI P OR 95% CI P
Males
Individual stigma
No stigma 38.2 31.5–45.5 1.41 0.97–2.06 0.08 1.40 0.97–2.03 0.07
Any stigma 61.8 54.5–68.6 REF – – REF – –
Village level stigma 59.3b 54.4–64.2 1.00 0.98–1.04 0.69 1.00 0.97–1.03 0.94
Females
Individual stigma
No stigma 76.1 65.9–84.0 0.80 0.45–1.41 0.44 0.68 0.37–1.27 0.23
Any stigma 23.9 16.1–34.1 REF – – REF – –
Village level stigma 58.9b 54.0–63.7 1.03 1.01–1.05 0.01 1.03 1.01–1.05 \0.01
a Controlled for age group, educational attainment, and community proportion of migrants
b Mean
levels of stigma. Individual reports of anticipated stigma
were excluded from our community-level indicators, pro-
viding a conservative estimate of an association of village
stigma with testing that was independent of individual
perceptions [37]. The implication is that men’s testing may
be most impacted by personally held fears; whereas
women’s testing behaviours may be more influenced by
community beliefs. Employing the g-computation algo-
rithm allowed us to understand the potential gains in HIV
testing for women that could be achieved on the population
level due to an intervention effect modifying community
levels of stigma.
Potential explanations of our findings regarding indi-
vidual level stigma and testing include differential access
to services for men and women and traditional gender
norms. Access could be a significant moderator in the
relationship between individual stigma and HIV-testing. As
reflected by the stark differences in recent HIV testing
across gender within our data, men are significantly less
likely to access care at the clinic than women [38–41].
Research in South Africa has found that men test and enter
care later, present with lower CD4 counts, and have worse
HIV-related outcomes than women [38–41]. Compara-
tively, women have much greater social access to clinic-
based testing. Women typically begin consistent engage-
ment in health care at a younger age then men due to
enrollment in reproductive health care for pregnancy and
family planning, thus HIV testing and diagnosis for women
may be more likely to occur within the context of a non-
HIV-related visit. Further, much HIV programming has
focused on engaging women in HIV testing and treatment
services largely because of their role in preventing trans-
mission to children [42]. Studies on gender differences in
engagement to care found that men’s absence from health
facilities is related to both traditional ideas of illness as a
Fig. 1 Proportion of females







We suspect that the inclusion of men who knew their HIV-
positive status but chose to report an HIV-negative status in 
our sample would bias our results towards the null 
hypothesis. While we make the assumption that self-re-
ported HIV status is a variable heavily susceptible to social 
desirability, we do not make that same assumption about 
HIV testing. As such, we suspect that the subset would still 
report recent HIV testing accurately. If these assumptions 
are correct, we would see high stigma reported and recent 
testing behaviour, biasing our results towards the null 
hypothesis.
Among women, the difference in stigma for those 
reporting a positive or negative status was minimal and 
75% of women reporting a positive status reported testing 
in the last year compared to 79% of women reporting a 
negative status (p = 0.52). As rates of exposure and out-
come were comparable between disclosing HIV-positive 
and all reporting negative women, there is some evidence 
that failure to report HIV-positive status among women, 
and thus erroneous inclusion in this analysis, would not 
influence the current findings. However, there is still some 
potential that women who are HIV-positive but do not 
disclose may differ and drive some findings in an unknown 
direction.
Discussion
Our research points to important differences in the rela-
tionship between stigma and HIV testing among men and 
women. We found that stigma influenced both men and 
women’s likelihood of recent HIV testing but through 
different mechanisms. Individually-held anticipated stigma 
was associated with men’s HIV testing uptake while 
women’s testing patterns were associated with community
sign of ‘‘weakness’’ and because clinics are viewed as a
woman’s realm [21, 43–45]. This focus on women may
have inadvertently exacerbated men’s differential struc-
tural and social access to HIV services [42]. Women’s
greater comfort level with clinic attendance may facilitate
testing diagnosis earlier in their infection, independently of
their individual-ideas of stigma [6]. It could be that without
the structural points of access for men to test for HIV (i.e.
socially acceptable pathways to clinic use), individual-
level anticipated stigma has a stronger influence over
testing behaviour.
Regarding community-level stigma and testing, we
explore social constructions of gender, the interaction
between gender norms and engagement with HIV in the
community, and differential migration patterns to explain
differences between men and women. Research on the
socialisation and psychology of women observes that
women’s decision-making is more heavily influenced by
the potential impact a decision could have on relationships
compared to men’s decision making [46, 47]. The impli-
cation is that women may be more sensitive to other’s
feelings around HIV and these social norms influence
women’s decision-making around testing. While this social
theory is based on US populations and may not be appli-
cable in the South African context, findings from a meta-
analysis of qualitative data with HIV-positive women in
the United States by Sandelowski et al. confirm that
women’s decision-making prioritizes others’ needs and
opinions over self [48]. Specifically, Sandelowski’s anal-
ysis found that women’s goals when managing disclosure
revolved around ‘‘preserving social relations and moral
identities and preventing harm to others’’ [48]. Relation-
ally-oriented decision-making may explain why community
levels of stigma more heavily influence women’s testing
uptake as compared to individual level stigma.
Relatedly, caretakers of those living with HIV in South
Africa are overwhelmingly women [49, 50]. This exposure
to the realities of PLHIV may allow women to better
understand the extent to which others fear HIV-related
stigma and to the level of stigmatising attitudes in their
communities. Indeed, when we explored differences in
reported anticipations of stigma between HIV-positive and
HIV-negative women, we saw almost identical percent-
ages—whereas the proportion of HIV-positive and HIV-
negative men anticipating stigma were dramatically dif-
ferent. This suggests that women’s expectations of HIV-
related stigma may be more similar to their experiences of
stigma, while men’s expectations of stigma may be more
severe than the true experiences of a person living with
HIV.
Finally, migration may serve to lessen the influence of
community norms, and thus the relationship between
stigma and HIV-testing, on men compared to women.
There are extremely high rates of employment-related
migration among males in this area—50–70% of men age
20–59 temporarily migrate out of the area for work [51].
Studies among migrant men have found lower rates of
HIV-testing, more sexual risk behaviour and a higher
prevalence of HIV [52, 53]. Migration introduces new
vulnerabilities, can reduce access to health care services
and, most relatedly, can lessen the influence of family and
cultural norms. The concept of liminality suggests that
when people are removed from their social environment
they experience ‘freedom’ from social obligations, result-
ing in different behaviour patterns when at home or as a
migrant [54]. This could explain why we do not see a
relationship between community-level stigma and HIV
testing among men in this area—men may feel less con-
strained by community social norms compared to women
as a result of migration patterns. It is important to note that
our sample excluded individuals who were currently
migrant. However, as the majority of men in the area have
been migrant previously and will likely be migrant again
we believe this is still a salient issue for men.
Previous research has not found consistent relationships
between stigma, HIV testing and gender. One study in
Nigeria demonstrated that men’s readiness to do an HIV
test, but not women’s, was influenced by the mean level of
stigma in the individual’s community [26]. These findings
are in contrast to ours, as are those from research in
Zimbabwe that found that ‘‘social rejection stigma’’
(measured by questions such as: If a female teacher has
HIV but is not sick, she should be allowed to continue
teaching in school) was associated with less testing for
women, but not men [55]. Further, in Eastern Cape, South
Africa, research found that women’s testing was influenced
by individual level stigma whereas men’s testing was
influenced by structural factors (i.e. availability of testing,
quality of testing, etc.) [56]. Some differences may result
from different scales and measures, however, they also
might reflect contextual or cultural differences. Social
phenomena such as stigma and gender norms are inherently
influenced by local social contexts; as such, any related
programming should be tailored to the local context to
ensure it reflects the specific ways in which gender and
stigma manifest themselves [57]. Further, as HIV treatment
becomes increasingly available in South Africa and else-
where, the relationship between HIV stigma and testing
may change [58–61]. The timing of our data collection, in
the context of rapidly changing HIV awareness, testing and
treatment campaigns, may explain differences in our results
compared to studies done previously and in other countries.
In our data, we found fewer people reported anticipated
stigma as compared to other studies on HIV-related stigma
and testing in Botswana and Kenya [17, 33]. Reported
recent HIV-testing for men was slightly lower and
populations were also likely to be excluded from the
prevalence surveys. More likely, this underreporting of
HIV-positive status could result from (1) a significant
proportion of people living with HIV in the area not
knowing their status [62] or (2) biases in self-reported
status driven by social desirability or discomfort in dis-
closing. Research conducted in the study site, which
included HIV testing, found that in 2010 only 20–30% of
people living with HIV in the area knew their status. More
recent estimates of national data from 2012 suggest that
55% of HIV-positive women and 37% of HIV-positive
men know their status [6]. Based on national rates of
known status, the age distribution of data and the age
distribution of the HIV epidemic in the area, we estimate
that around half of the underreporting for men and 40% of
the underreporting for women is due to not knowing their
status. We theorized that the remaining bias would likely
manifest itself as higher rates of stigma among recent
testers (i.e. people who have tested positive but are
reporting a negative status due to fears of stigma), atten-
uating effect estimates.
These findings have implications for gender-based pro-
gramming, including crafting stigma reduction program-
ming through a gendered-lens and specifically considering
the social context of stigma. To increase men’s HIV test-
ing, programs are needed that both reduce men’s personal
fears around stigma, challenge traditional ideas of mas-
culinity that act as a barrier to engaging in health care, and
create alternative environments where men can access
testing services, such as home-based or self-testing or
testing in majority-male spaces. Community, social or
familial based intervention approaches—such as commu-
nity mobilization to reduce stigma —may be more suc-
cessful for women. Our intervention modelling suggests
that modifying community levels of stigma could lead to
important potential gains in HIV testing for women. Efforts
to increase HIV testing are imperative to end the HIV
epidemic. Carefully accounting for and responding to HIV-
related stigma continues to be paramount in removing
social barriers to engagement in HIV prevention, testing
and treatment. Stigma operates within internal and social
planes; as such, intervention development must also target
points of environmental influence on behaviour.
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recent testing [6]. High testing uptake among women is 
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efforts to test all pregnant women and women accessing 
family planning services; unfortunately, pregnancy indi-
cators were not collected in the survey but the sample does 
consist of women in a key child-bearing age category. We 
only examined the relationship between stigma and testing 
in the last 12 months. As our sample focused on young 
adults age 18–35 in an area with extremely high prevalence 
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most, participants. However, there may be some individ-
uals at low risk who tested over a year ago. Given the 
sample demographics, the high HIV prevalence of the area 
and the recent evolution of HIV services in South Africa, 
we felt that looking at the most proximal behavior (i.e. 
recent HIV testing) was most appropriate.
Our research has some limitations. Our data is cross-
sectional; thus we cannot interpret these associations as 
causal. This data was collected in 2012; as previously 
mentioned, the relationship between stigma and testing 
may change over time as HIV treatment becomes 
increasingly available. Recently collected qualitative data 
from South Africa suggests that stigma remains a barrier to 
HIV testing but through different mechanisms for men and 
women [21]. Our sample of men and women aged 18–35 
included more young men (age 18–24) than women, 
potentially because older men may be working or have 
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results. We used aggregated individual-level data to mea-
sure community-level stigma which has limitations. How-
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community members and by the fact that the variable was 
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or pregnancy in our analysis as this data was not available. 
The relationship between HIV testing and stigma in sub-
populations such as migrants, sex workers, and care takers 
of people living with HIV merits further research. This 
could provide additional interesting insights into the rela-
tionship between community-level stigma and HIV testing.
It is of note that only 2% of men and 6.9% of women 
self-reported HIV-positive status, which is significantly 
lower than documented HIV prevalence, which ranges 
from 6.1% (age 20–24) to 41.8% (age 30–34) among men 
and from 27% (age 20–24) to 41.8% (age 30–34) among 
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bias through exclusion of migrants as our eligibility criteria 
only include people who spent the majority of nights in a 
7-day week within the home. However migrant
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